Gephardt-Led Group Steps Up Medical Innovation Lobbying Effort
This article was originally published in The Gray Sheet
Executive Summary
An advocacy group headed by former U.S. House Majority Leader Dick Gephardt is launching a coordinated lobbying effort to improve federal policies impacting medical innovation, including calls to strengthen the R&D tax credit and make FDA oversight more predictable